Inventor · disambiguated record
Mia Levite
Also filed as: LEVITE MIA
3 granted patents·4 pending applications·5 citations·filing 2002–2019
53Inventor score
Files withLEVITE MIA6
Top patents by PatentIndex Score
7 records- 0171US8859001B2Fenoldopam formulations and pro-drug derivativesLEVITE MIA·Filed 2008·Granted Oct 14, 2014·5 cites·21 claims
- 0242US2009221069A1Method for augmenting the ability of t-cells and other cells for fighting disease and invade diseased organs, for elevating cd3 zeta and tnf-alpha expression in t-cells, and mixing t-cell boosting and kit particularly useful in such methodLEVITE MIA·Filed 2006·Application pending·0 cites
- 0341US2008311657A1Killing Human Lymphoma and Leukemia Cancer Cells and Tcr-Activated Normal Human Cells By Dopamine D1r AgonistsLEVITE MIA·Filed 2006·Application pending·0 cites
- 0441US2009022739A1MODULATING THE KV1.1 VOLTAGE-GATED POTASSIUM CHANNEL IN T-CELLS FOR REGULATING THE SYNTHESIS AND SECRETION OF TUMOR NECROSIS FACTOR ALPHA (tnf-ALPHA) AND TREATING HUMAN DISEASE OR INJURIES MEDIATED BY DETRIMENTALLY HIGH OR LOW LEVELS OF TNF-ALPHALEVITE MIA·Filed 2006·Application pending·0 cites
- 0540US12455279B2Personalized immunotherapy for rejuvenating activating and strengthening exhausted and dysfunctional T cells, reducing PD-1, and improving immune functionLEVITE MIA·Filed 2019·Granted Oct 28, 2025·0 cites·13 claims
- 0635US7951775B2Methods and pharmaceutical compositions for GnRH-I and GnRH-II modulation of T-cell activity, adhesion, migration and extravasationLEVITE MIA·Filed 2002·Granted May 31, 2011·0 cites·28 claims
- 0735US2005163773A1Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and activityFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mia Levite files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →